National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Send to Printer
Cognitive Disorders and Delirium (PDQ®)     
Last Modified: 10/02/2009
Health Professional Version
Changes to This Summary (10/02/2009)

The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.

General Management Approach to Delirium 1

Added text 2 on the intravenous use of haloperidol (cited US Food and Drug Administration as reference 25 and Hassaballa et al. as reference 26).

Added text 3 on the use of palliative sedation for intractable symptoms in the palliative care unit of a comprehensive cancer center (cited Elsayem et al. as reference 45).



Table of Links

1http://www.cancer.gov/cancertopics/pdq/supportivecare/delirium/HealthProfession
al/35.cdr#Section_35
2http://www.cancer.gov/cancertopics/pdq/supportivecare/delirium/HealthProfession
al/45.cdr#Section_45
3http://www.cancer.gov/cancertopics/pdq/supportivecare/delirium/HealthProfession
al/59.cdr#Section_59